Femiguard
Retrievable Fallopian Tube Occlusion Device
Startup Seed Health Tech & Life Sciences Est. 2020
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
88/100
About
Femiguard offers a safe and effective solution for infertile women diagnosed with hydrosalpinx as well as for women seeking reversible nonhormonal contraception. The Feminity device is specifically designed to block the ostium of the fallopian tube, preventing the spillage of undesired fluids into the uterine cavity and resulting in increased IVF implantation rates. The device’s unique shape and structure is also designed to accommodate periodic contractions of the uterus and fallopian tubes.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target Customer
Healthcare & Life SciencesHealthcareProvidersConsumersDemographics & FamilyWomen
Business Model
B2B
Tags
women-healthtreatmentsfemtechmedical-devicesfertility
Funding & Events
Nov 2021
Undisclosed Round Undisclosed
Sanara Ventures (Lead)
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
2
Founded
2020
Registrar
516269578
Locations
Zarhin St 13, Ra'anana, Israel
Links
Website
LinkedIn
Admin
Last Update
Sep 1, 2025
Verified by
Yanina Wainscheinker
Missing
video or image, news, markets, not claimed
Team (2)
Shlomi Cohen
Co-founder & CMO
Founder
Tamir Ben David
Co-founder & CTO
Internal
Created by
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Created
2022-12-16T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)